$3076 | SAVE $419 | Single User
$6151 | SAVE $839 | Site License
$9227 | SAVE $1,258 | Global License

Seasonal Influenza: Competitive Landscape to 2026
[Report Updated: 08-11-2018]

Published by Global Data: 08 Nov 2018 | 227771 | In Stock
Related Topics: Clinical Trials

Introduction

Seasonal Influenza: Competitive Landscape to 2026

Summary

Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. The influenza A H1N1 and H3N2, and influenza B strains are those responsible for seasonal influenza infections. The symptoms of influenza are similar to those of the common cold, though they are usually more severe, have a sudden onset, last for one to two weeks, and are normally self-limiting without medical treatment. The very young, elderly, and patients with chronic illness such as diabetes, asthma, or cardiovascular disease are most at risk of complications due to influenza.

This report provides an assessment of the pipeline, clinical, and commercial landscape of seasonal influenza. Overall, GlobalData expects new drug approvals to drive a shift in the treatment and prophylaxis of seasonal influenza over the next decade (2016-2026).

Scope

This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include -

- Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by product type

- Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics

- Commercial Assessment: leading marketed products, current and future players

- Competitive Landscape Analysis: key market events (2016-2026).

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global seasonal influenza market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global seasonal influenza market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents
for Seasonal Influenza: Competitive Landscape to 2026 [Report Updated: 08-11-2018]

  • Table of Contents

    1. Preface 2

    1.1 Table of Contents 2

    1.2 Abbreviations 3

    1.3 Related Reports 4

    1.4 Upcoming Related Reports 5

    2. Executive Summary 6

    2.2 Key Findings 7

    2.2 Key Events 8

    3. Introduction 9

    3.1 Report Scope 10

    3.2 Disease Overview and Epidemiology 12

    4. Pipeline Assessment 15

    4.1 Pipeline Overview 16

    4.2 Pipeline Breakdown by Region/Country 18

    4.3 Pipeline Breakdown by Molecule Type and Target 19

    4.4 Drug Review Designations 20

    4.5 Products in Clinical Development 21

    5. Clinical Trial Assessment 23

    5.1 Clinical Trials Overview 24

    5.2 Top Sponsors of Clinical Trials in Seasonal influenza 25

    5.3 Trial Breakdown by Region 27

    5.4 Therapy Area Perspective 28

    5.5 Enrollment Analytics 29

    6 Commercial Assessment 32

    6.1 Leading Marketed Products 33

    6.2 Current & Future Players 34

    7. Competitive Landscape Analysis (2016-2026) 35

    7.1 Events Classification Overview 36

    7.2 US 37

    7.3 5EU 38

    7.4 Japan 39

    8 Appendix 40

    8.1 Sources 41

    8.2 Methodology 42

    8.3 Key Events Included in the Analysis 43

    8.4 About the Authors 44

    8.5 About GlobalData 47

    8.6 Disclaimer 49

Additional Details

Publisher

Global Data

Publisher Information

Reference

227771 | GDHC020CL

Number of Pages

49

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 12% today! Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast,2016 to 2022
Seasonal Influenza Vaccine Market is expected to reach more than US$ 4 Billion across the seven majo...
21 Nov 2016 by DPI Research USD $1,760 (normally
USD $2,000)
More Info
SAVE 12% today! EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025
EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025SummaryInfluenza, commonly known a...
01 Nov 2016 by Global Data USD $3,516 (normally
USD $3,995)
More Info
SAVE 12% today! EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025
EpiCast Report: Seasonal Influenza - Epidemiology Forecast to 2025SummaryInfluenza, commonly known a...
01 Nov 2016 by Global Data USD $3,516 (normally
USD $3,995)
More Info
SAVE 12% today! PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025
PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025SummaryIn...
01 Nov 2016 by Global Data USD $9,676 (normally
USD $10,995)
More Info
SAVE 12% today! Seasonal Influenza Vaccines - US Drug Forecast and Market Analysis to 2025
Seasonal Influenza Vaccines - US Drug Forecast and Market Analysis to 2025SummaryInfluenza, often re...
01 Nov 2016 by Global Data USD $4,396 (normally
USD $4,995)
More Info
SAVE 12% today! Seasonal Influenza Vaccines - Japan Drug Forecast and Market Analysis to 2025
Seasonal Influenza Vaccines - Japan Drug Forecast and Market Analysis to 2025SummaryInfluenza, often...
01 Nov 2016 by Global Data USD $4,396 (normally
USD $4,995)
More Info
SAVE 12% today! Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016
Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial...
30 Sep 2016 by Global Data USD $2,200 (normally
USD $2,500)
More Info
SAVE 12% today! Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinica...
27 Jul 2016 by Global Data USD $2,200 (normally
USD $2,500)
More Info
SAVE 12% today! Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinica...
27 Jul 2016 by Global Data USD $2,200 (normally
USD $2,500)
More Info
SAVE 12% today! Seasonal Influenza Global Clinical Trials Review, H2, 2015
Seasonal Influenza Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report,...
30 Dec 2015 by Global Data USD $2,200 (normally
USD $2,500)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Seasonal Influenza: Competitive Landscape to 2026 [Report Updated: 08-11-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...